Maitri Enterprises Ltd

Maitri Enterp. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Maitri Enterprises Ltd

₹ 43.6 4.08%
20 May - close price
maitrienterprises.com BSE: 513430
About

Incorporated in 1991, Maitri Enterprises Ltd trades in Pharmaceutical & Medical Goods.[1]

Key Points

Business Overview:[1][2]
MEL is engaged in trading of Pharmaceutical & Medical Goods in Gujarat. This includes sale of service by way of works contract. Apart from this, the co. is also in the business of Infra
structure and Real Estate.

Website BSE
  • Market Cap ₹ 19.2 Cr.
  • Current Price ₹ 43.6
  • High / Low ₹ 44.7 / 22.1
  • Stock P/E 32.0
  • Book Value ₹ 12.0
  • Dividend Yield 0.00 %
  • ROCE 15.0 %
  • ROE 12.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter
  • Debtor days have improved from 97.9 to 56.9 days.
  • Company's working capital requirements have reduced from 87.9 days to 36.0 days

Cons

  • Stock is trading at 3.65 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 7.74% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Metals & Mining Non - Ferrous Metals Aluminium

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
4.00 3.49 3.27 5.94 6.31 7.72 7.34 7.71 5.88 6.97 7.76 4.66 13.91
3.78 3.41 3.19 5.68 6.49 7.45 6.38 6.45 6.18 7.67 7.45 3.77 13.11
Operating Profit 0.22 0.08 0.08 0.26 -0.18 0.27 0.96 1.26 -0.30 -0.70 0.31 0.89 0.80
OPM % 5.50% 2.29% 2.45% 4.38% -2.85% 3.50% 13.08% 16.34% -5.10% -10.04% 3.99% 19.10% 5.75%
0.08 0.00 0.01 0.18 0.02 0.00 0.08 -1.02 -0.06 0.07 0.30 0.01 0.04
Interest 0.16 0.08 0.07 0.15 0.44 0.04 0.42 0.19 0.13 0.18 0.20 0.19 0.15
Depreciation 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.01
Profit before tax 0.12 -0.01 0.01 0.27 -0.62 0.21 0.60 0.03 -0.51 -0.83 0.39 0.68 0.68
Tax % 33.33% 0.00% 0.00% 70.37% -24.19% 28.57% 26.67% 1,433.33% -96.08% -16.87% -5.13% 39.71% 30.88%
0.07 -0.01 0.00 0.09 -0.46 0.15 0.43 -0.39 -0.02 -0.70 0.41 0.42 0.47
EPS in Rs 0.16 -0.02 0.00 0.20 -1.05 0.34 0.98 -0.89 -0.05 -1.59 0.93 0.95 1.07
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4.55 19.92 13.26 19.01 28.66 33.30
4.47 19.23 12.76 18.76 26.48 32.01
Operating Profit 0.08 0.69 0.50 0.25 2.18 1.29
OPM % 1.76% 3.46% 3.77% 1.32% 7.61% 3.87%
0.09 0.06 0.11 0.13 -1.01 0.42
Interest 0.02 0.32 0.37 0.73 0.77 0.71
Depreciation 0.05 0.09 0.07 0.06 0.07 0.08
Profit before tax 0.10 0.34 0.17 -0.41 0.33 0.92
Tax % 40.00% 32.35% 94.12% 9.76% 48.48% 34.78%
0.07 0.23 0.00 -0.45 0.17 0.60
EPS in Rs 0.37 0.52 0.00 -1.02 0.39 1.36
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 49%
3 Years: 36%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 54%
3 Years: %
TTM: -38%
Stock Price CAGR
10 Years: %
5 Years: 31%
3 Years: 26%
1 Year: 76%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 8%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4.40 4.40 4.40 4.40 4.40
Reserves 0.57 0.57 0.12 0.30 0.86
5.72 6.34 10.54 6.89 4.83
6.85 7.09 6.61 4.77 4.55
Total Liabilities 17.54 18.40 21.67 16.36 14.64
0.28 0.24 0.24 0.24 0.39
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.27 0.27 3.92 3.74 3.74
16.99 17.89 17.51 12.38 10.51
Total Assets 17.54 18.40 21.67 16.36 14.64

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.39 0.02 0.06 3.04 3.09
-3.27 -0.24 -3.45 1.23 -0.24
3.69 0.24 3.49 -4.40 -2.76
Net Cash Flow 0.03 0.02 0.10 -0.12 0.09
Free Cash Flow -0.41 -0.01 0.00 2.96 2.86
CFO/OP -41% 38% 92% 148% 250%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 163.81 205.62 168.00 68.90 56.89
Inventory Days 210.48 261.85 149.78 102.88 68.38
Days Payable 186.79 206.97 122.59 78.10 66.06
Cash Conversion Cycle 187.50 260.50 195.19 93.68 59.20
Working Capital Days 157.40 247.74 176.07 51.58 35.95
ROCE % 4.91% 2.43% 15.83% 15.04%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Trade Receivables Turnover
Ratio ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Revenue Contribution - Pharmaceutical Goods
Percentage ・Standalone data
Revenue from Clearing & Forwarding Services
INR Lakhs ・Standalone data
Revenue from Infrastructure / Works Contract Services
INR Lakhs ・Standalone data
Net Capital Turnover Ratio
Ratio ・Standalone data
Number of Permanent Employees
Number ・Standalone data
Number of Pharma Distribution Rights (Companies)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01% 63.01%
36.99% 36.99% 37.00% 36.99% 37.00% 36.99% 36.99% 37.00% 37.00% 37.00% 37.00% 37.00%
No. of Shareholders 12,23212,20412,13712,09012,07512,05912,04312,02812,02512,03912,04612,009

Documents

Announcements

Annual reports